JULIA WIEDMEIER, M.D.
Hematology & Oncology Physician · SCOTTSDALE, AZ
Individual Active NPI 1457883035
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 697 | 128,489 | $13,267,648 | $3,287,170 | $2,621,218 |
| 2023 | 183 | 17,232 | $1,864,797 | $462,497 | $368,671 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 12,600 | $49 | $39 |
| J9271 | Injection, pembrolizumab, 1 mg | 9,200 | $54 | $43 |
| J1453 | Injection, fosaprepitant, 1 mg | 7,500 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 6,700 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 3,444 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,420 | $26 | $21 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,310 | $45 | $36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,180 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,010 | $1 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 764 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 735 | $2 | $1 |
| 96375 | Injection of additional new drug or substance into vein | 392 | $15 | $12 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 57603 | AZ |
| Internal Medicine Physician | 207R00000X | R76263 | AZ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Arizona
- NPI 1821065830
- NPI 1548246655
- NPI 1346223013
- NPI 1891363891
- NPI 1255568135
- NPI 1003122573
- NPI 1902870959
- NPI 1841243722
See all Hematology & Oncology Physician providers in Arizona →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.